Related Experiment Video
Updated: Oct 9, 2026

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice
Published on: June 29, 2022
Ventricular fibrillation induced by rapid atrial rates in patients with hypertrophic cardiomyopathy
M López Gil1, F Arribas, F G Cosío
1Servicio de Cardiología, Hospital 12 de Octubre, Carretera de Andalucía, km 5,4, 28041 Madrid, Spain.
Insights
Rapid atrial rates can induce ventricular fibrillation (VF) in hypertrophic cardiomyopathy (HCM) patients. Atrioventricular junctional ablation may prevent VF in select cases.
Area of Science:
- Cardiology
- Electrophysiology
- Genetics
Background:
- Hypertrophic cardiomyopathy (HCM) is a genetic heart muscle disease.
- Rapid atrial rates are a known trigger for arrhythmias in HCM patients.
Observation:
- Three HCM patients underwent electrophysiological studies for VF induced by rapid atrial rates.
- VF was induced by atrial pacing in all patients, with QRS widening preceding fibrillation.
- Mechanisms included electrophysiological instability and potential ischemic events.
Findings:
- Rapid atrial rates triggered ventricular fibrillation (VF) in some hypertrophic cardiomyopathy (HCM) patients.
- Atrioventricular (AV) junctional ablation was effective in preventing VF recurrence in two patients.
- Pacemaker implantation successfully managed syncope in a patient with post-atrial fibrillation pauses.
Implications:
- Understanding the mechanisms of VF induction by rapid atrial rates is crucial for HCM management.
- AV junctional ablation is a potential strategy to prevent VF in selected HCM patients.
- Further research into the interplay of electrophysiological and ischemic mechanisms is warranted.
Aims:
To describe the mechanisms of induction of ventricular fibrillation (VF) by rapid atrial rates in patients with hypertrophic cardiomyopathy (HCM).
Methods:
Electrophysiological studies, management and follow-up in three patients with HCM with VF induced by atrial pacing.
Results:
In one patient, spontaneous sinus tachycardia triggered VF. In another patient, VF occurred after verapamil infusion during rapid atrial fibrillation, and in the remaining patient there was no clinical VF. In all three patients, short runs of atrial pacing (cycle length 272-380 ms) induced VF, and QRS widening preceded fibrillation in all patients. Marked ventricular electrogram fragmentation was documented in one patient during atrial pacing and in another patient during late ventricular extra-stimuli. Hypotension was associated with sinus tachycardia in one patient. The two patients developing clinical VF underwent atrioventricular (AV) junctional ablation; a ventricular defibrillator was implanted in one, and a mode-switching dual-chamber pacemaker in the other. No arrhythmic events occurred during 34- and 35-month follow-up, respectively. In the other patient, postatrial fibrillation pauses caused syncope, and he is asymptomatic 52 months after implantation of a dual-chamber pacemaker.
Conclusions:
Rapid atrial rates can trigger VF in some patients with HCM, probably through a combination of electrophysiological and ischaemic mechanisms. AV junctional ablation may prevent VF in selected cases.
Related Concept Videos
Dysrhythmias III: Characteristics of Dysrhythmias
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Dysrhythmias II: Classification of Tachyarrhythmias
Dysrhythmias IV: Characteristics of Bradyarrhythmias
Mechanism of Cardiac Arrhythmias

